Dawn Mchugh BS, MS

MMs. McHugh joined the Company in 2017. Prior to joining Corgenix, Dawn was a Director of Pharma Partnering at QIAGEN, where she spent 5.5 years as a member of the Companion Diagnostics Business Development Team, responsible for establishing collaborations with Pharma, for the development, registration and commercialization of Molecular Companion Diagnostics. Prior to joining QIAGEN, Dawn worked at LLNS in NYC and managed the advertising team that developed a global campaign for the launch of a first-in-class therapy for the treatment of ALK-positive non-small cell lung carcinoma (NSCLC).
Dawn’s other experience spans the oncology therapeutic and diagnostic markets with roles at AstraZeneca (Oncology Sales), Becton Dickinson (Oncology Diagnostic Marketing), and Oncor, Inc. (Diagnostic Sales, Product Management and Marketing). Ms. McHugh holds a Bachelor’s of Science degree in Biology from Stony Brook University in Stony Brook, New York and a Master’s of Science degree in Human Cytogenetics from Hofstra University in Hempstead, NY.